| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 01/12/2006 | US20060009470 Method for specifically potentiating N-type Ca2+ channel activity |
| 01/12/2006 | US20060009467 Novel gamma secretase inhibitors |
| 01/12/2006 | US20060009465 Treatment of sleep disorders using sleep target modulators |
| 01/12/2006 | US20060009464 4-(3-Phenyl-3-carbocycloylpropyl)-1-phenyl- or pyridylpiperazine derivatives: 1-(2-methoxyphenyl)-4-[3-(benzoyl)-3-(phenyl)propyl]piperazine oxalate; serotonin receptor antagonists; Alzheimer's disease |
| 01/12/2006 | US20060009462 Prodrugs of CC-1065 analogs |
| 01/12/2006 | US20060009446 New compounds |
| 01/12/2006 | US20060009439 Novel physiologically active substances |
| 01/12/2006 | US20060009438 Administering steroid (such as estrogen) containing hydrophobic substitutions such as adamantane ring; therapy for Alzheimer's, Parkinson's, huntington's disease; multiple sclerosis; amyotrophic lateral sclerosis; strokes; antiischemic agents |
| 01/12/2006 | US20060009412 Methods and compositions useful for modulation of angiogenesis using tyrosine kinase Src |
| 01/12/2006 | US20060009409 Double-stranded oligonucleotides |
| 01/12/2006 | US20060009397 New use |
| 01/12/2006 | US20060009390 Dose of an angiogenic factor and method of administering to improve myocardial blood flow |
| 01/12/2006 | US20060009380 Isolated deoxyribonucleic acid fragment that codes for the calcium binding proteins; treating skin disorders, like dry skin, hyperkeratosis, parakeratosis, psoriasis, ichthyosis, and neoplasia; cosmetics |
| 01/12/2006 | US20060008889 Phosphatase specific immunoglobulin for use in diagnosis, prevention and treatment of cell proliferative, autoimmune, muscular and graft vs. host diseases |
| 01/12/2006 | US20060008882 Antibody or fragment that specifically binds to CK alpha -5 polypeptides; may be chimeric antibody or fragment thereof, a single chain antibody, a Fab fragment, or a F(ab')2 fragment; Western blot or an enzyme-linked immunosorbent assay; hybridoma that produces the antibody |
| 01/12/2006 | US20060008842 Method of measuring neprilysin activity |
| 01/12/2006 | US20060008797 Peptide that that binds to microglial receptors; may be conjugated to a carrier molecule that increases transport across the blood-brain barrier; treating neurological effects of cerebral ischemia or cerebral inflammation |
| 01/12/2006 | US20060008459 Combination therapy of respiratory diseases using antibodies |
| 01/12/2006 | CA2572874A1 Urea derivative |
| 01/12/2006 | CA2572872A1 Tissue factor production inhibitor |
| 01/12/2006 | CA2572129A1 Viral particle-like construct and method of forming the same under physiological conditions |
| 01/12/2006 | CA2570318A1 Biaryl derivatives |
| 01/12/2006 | CA2569530A1 Thienopyrazole derivative having pde 7 inhibitory activity |
| 01/11/2006 | EP1614697A1 Proteoglycan isolated from cartilaginous fish and process for producing the same |
| 01/11/2006 | EP1614694A1 Titanium dioxide complex having molecule distinguishability |
| 01/11/2006 | EP1614684A1 Diamine derivative, production process, and antioxidizing drug |
| 01/11/2006 | EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use |
| 01/11/2006 | EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives |
| 01/11/2006 | EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them |
| 01/11/2006 | EP1614432A2 Method for treating amyloidosis |
| 01/11/2006 | EP1614428A1 Drug for preventing or treating angiogenic eye diseases |
| 01/11/2006 | EP1614425A2 Leukotriene receptor antagonist |
| 01/11/2006 | EP1614421A2 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 01/11/2006 | EP1614416A2 Method for treating amyloidosis |
| 01/11/2006 | EP1613663A1 Cross-linked polysaccharide composition |
| 01/11/2006 | EP1613554A1 Functionalized carbon nanotubes, a process for preparing the same and their use in medicinal chemistry |
| 01/11/2006 | EP1613313A1 2-phenyl-benzimidazol and 2-phenyl-imidazo-4,5!-pyridine derivatives as checkpoint kinase cds1 (chk2) inhibitors for the treatment of cancer |
| 01/11/2006 | EP1469887A4 Compositions and methods for use of bioactive agents derived from sulfated and sulfonated amino acids |
| 01/11/2006 | EP1469743A4 Stable hygroscopic compositions and methods for stabilizing hygroscopic ingredients |
| 01/11/2006 | EP1442036B1 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1 |
| 01/11/2006 | EP1442035B1 Process for the preparation of 4- (8-chloro-5, 6-dihydro-11h-benzo-[5,6]-cyclohepta-[1,2-b]-pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester (loratadine) |
| 01/11/2006 | EP1435986A4 Igf-binding protein-derived peptide or small molecule |
| 01/11/2006 | EP1414481B1 Use of cetrorelix for the treatment of jacob-creutzfeldt-disease |
| 01/11/2006 | EP1392830B1 Interleukin-18 mutants, their production and use |
| 01/11/2006 | EP1385489B1 Coated granules based on angiotensin-converting enzyme inhibitor |
| 01/11/2006 | EP1366036B1 Compounds having activity as inhibitors of cytochrome p450rai |
| 01/11/2006 | EP1341412B1 Indolocarbazole anticancer agents and methods of using them |
| 01/11/2006 | EP1294924B1 Competitive assay for identifying allosteric inhibitors |
| 01/11/2006 | EP1294402B1 Compounds with a sulphonamide group and pharmaceutical compositions containing these compounds |
| 01/11/2006 | EP1256342B1 Hypoglycemics comprising organic zinc (ii) complexes |
| 01/11/2006 | EP1131315B1 Polyhydroxylated heterocyclic derivatives as anti-coagulants |
| 01/11/2006 | EP1056732B1 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases |
| 01/11/2006 | EP1047422B1 Use of histamine for elevating blood histamine levels |
| 01/11/2006 | EP1037632B1 Benzothiazole protein tyrosine kinase inhibitors |
| 01/11/2006 | EP0930883B1 Neurotrophin antagonists for the treatment of epilepsy, alzheimer's disease and pain |
| 01/11/2006 | CN1720326A Method of strengthening foreign epitope presentation by MHC class I by inhibiting TAP activity |
| 01/11/2006 | CN1720265A Chitosan-containing polysaccharide, method for preparing the same and use thereof |
| 01/11/2006 | CN1720257A Methods of down regulating target gene expression in vivo by introduction of interfering RNA |
| 01/11/2006 | CN1720235A 1-N-phenylamino-1h-imidazole derivatives as aromatase inhibitors |
| 01/11/2006 | CN1720040A Remedy |
| 01/11/2006 | CN1720038A Gabapentin analogues for fibromy algia and other disorders |
| 01/11/2006 | CN1720034A Methods of inducing terminal differentiation |
| 01/11/2006 | CN1720033A Water-soluble composition containing coenzyme q10 |
| 01/11/2006 | CN1718585A Sealing TGF-betal antisensedingonucleotides and its use in preparing medicine for treating fibrillation related disease |
| 01/11/2006 | CN1718245A Nucleic acid vaccine, and its application |
| 01/11/2006 | CN1718209A Traditional Chinese medicine prescription for making user being younger |
| 01/11/2006 | CN1235900C Thioether substituted imidazoquinolines |
| 01/11/2006 | CN1235877C Substd. N-phenyl-2-hydroxy-2-methyl-3,3,3-trifluoropropanamide derivs. which elevate pyruvate dehydrogenase activity |
| 01/11/2006 | CN1235875C Substituted alpha hydroxy acid aspertate specific cysteine protease inhibitors and use thereof |
| 01/11/2006 | CN1235870C Novel use of phenyl hetero alkylamine derivatives |
| 01/11/2006 | CN1235638C Activated protein C formulations |
| 01/11/2006 | CN1235594C Cell growth regulating factor Q and its prepn process |
| 01/11/2006 | CN1235593C Regulatory factor T for cell growth, and its prepn. method |
| 01/11/2006 | CN1235586C Improved releasing composition and use thereof |
| 01/11/2006 | CN1235583C Benzimidazole derivatives as therapeutic agents |
| 01/11/2006 | CN1235579C Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| 01/10/2006 | US6984664 Reduce side effect; analgesics |
| 01/10/2006 | US6984661 for preventing, Syndrome X, diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis, and other disorders related to Syndrome X and cardiovascular diseases; peroxisome proliferator activated receptor (PPAR) |
| 01/10/2006 | US6984660 To treat and/or prevent hypertension, cardiac hypertrophy, cardiac insufficiency, coronary heart diseases such as angina pectoris, and endothelial dysfunction or endothelial damage as a consequence of atherosclerotic processes or diabetes |
| 01/10/2006 | US6984657 Indole derivatives as MCP-1 receptor antagonists |
| 01/10/2006 | US6984655 Photodynamic therapy for selectively closing neovasa in eyeground tissue |
| 01/10/2006 | US6984653 useful as a growth factor receptor tyrosine kinase HER2 (Human epidermal growth factor receptor-2) inhibitor; for treating cancer |
| 01/10/2006 | US6984651 Piperidine amides as modulators of chemokine receptor activity |
| 01/10/2006 | US6984649 Pyridine derivatives |
| 01/10/2006 | US6984648 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 01/10/2006 | US6984647 Antiinflammatory agents; analgesics; antiarthritic agents |
| 01/10/2006 | US6984646 suitable for the preparation of medicaments for the treatment of diseases associated with p38 MAP kinase such as atherosclerosis, diabetes, adult respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, fever etc |
| 01/10/2006 | US6984641 Carboline derivatives as PDE5 inhibitors |
| 01/10/2006 | US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists |
| 01/10/2006 | US6984624 Composition containing an iron complexing protein and a precursor of nitrogen monoxide metabolism and/or a chemical donor of nitrogen monoxide and uses thereof |
| 01/10/2006 | US6984623 Tendon-inducing compositions |
| 01/10/2006 | US6984405 Compositions for inducing secretion of insulin-like growth factor-1 |
| 01/10/2006 | US6984391 Mixture containing ammonium salt; gradient adjustment of pH; skin disorders, acne |
| 01/10/2006 | CA2485556C Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group |
| 01/10/2006 | CA2381513C Bicyclic-substituted 4-amino-pyridopyrimidine derivatives |
| 01/10/2006 | CA2373395C Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| 01/10/2006 | CA2364178C N-benzenesulfonyl l-proline compounds as bradykinin antagonists |
| 01/10/2006 | CA2327758C (4-arylsulfonylamino)-tetrahydropyran-4-carboxylic acid hydroxamides |
| 01/10/2006 | CA2262252C Method of treating heart failure |
| 01/10/2006 | CA2129990C Benzodiazepin derivatives useful as cck-receptor antagonists |